Impact of OCT4 and Its Related Signaling Pathways on Gastrointestinal Cancers: Focusing on Targeted Therapy

被引:7
作者
Cheshomi, Hamid [1 ]
Gholami, Omid [1 ]
Peyroshabani, Babak [2 ]
Rad, Abolfazl [1 ]
机构
[1] Sabzevar Univ Med Sci, Cellular & Mol Res Ctr, POB 9816745639, Sabzevar, Iran
[2] Sabzevar Univ Med Sci, Clin Res Dev Unit, Sabzevar, Iran
关键词
Colorectal cancer; Esophageal neoplasms; Stomach neoplasms; STEM-CELL MARKERS; HUMAN EMBRYONIC STEM; COLORECTAL-CANCER; GASTRIC-CANCER; COLON-CANCER; GENE-EXPRESSION; ESOPHAGEAL CANCER; MESENCHYMAL TRANSITION; PROGNOSTIC VALUE; PROSTATE-CANCER;
D O I
10.18502/ijaai.v19i3.3451
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
There are many pieces of evidence support the effect of cancer stem cells on the initiation and progression of cancer. However, related mechanisms involved in these phenomena are far more complicated to understand. The function of different stemness factorsin cancer stem cells (CSCs) and their complex associations at different levels of cancer have been reported. Therefore, it seems that focusing on one master factor would be more helpful to complete the puzzle of singling pathways in these cells. Octamer-binding transcription factor 4 (OCT4) also known as POU domain, class 5, transcription factor 1(POU5F1), one of these key pluripotency factors, has important roles in both embryogenesis and tumorigenesis. In this review, we gathered information about the association of different markers with OCT4 expression in three types of gastrointestinal cancers including esophageal, gastric and colorectal cancers. OCT4 through different signaling pathways has an impact on different processes of gastrointestinal cancers such as proliferation, invasion, and metastasis. Based on the literature, OCT4 has great effects on cancer progression at different stages, therefore we suggested it has potential implications in therapeutic options.
引用
收藏
页码:229 / 242
页数:14
相关论文
共 137 条
[71]   Human embryonic genes re-expressed in cancer cells [J].
Monk, M ;
Holding, C .
ONCOGENE, 2001, 20 (56) :8085-8091
[72]   Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma Final Results and Analysis of Prognostic Factors [J].
Motzer, Robert J. ;
Escudier, Bernard ;
Oudard, Stephane ;
Hutson, Thomas E. ;
Porta, Camillo ;
Bracarda, Sergio ;
Grunwald, Viktor ;
Thompson, John A. ;
Figlin, Robert A. ;
Hollaender, Norbert ;
Kay, Andrea ;
Ravaud, Alain .
CANCER, 2010, 116 (18) :4256-4265
[73]   The role of pluripotency factors to drive stemness in gastrointestinal cancer [J].
Mueller, Martin ;
Hermann, Patrick C. ;
Liebau, Stefan ;
Weidgang, Clair ;
Seufferlein, Thomas ;
Kleger, Alexander ;
Perkhofer, Lukas .
STEM CELL RESEARCH, 2016, 16 (02) :349-357
[74]   Cancer stem cell subpopulations in primary colon adenocarcinoma [J].
Munro, Matthew J. ;
Wickremesekera, Susrutha K. ;
Peng, Lifeng ;
Marsh, Reginald W. ;
Itinteang, Tinte ;
Tan, Swee T. .
PLOS ONE, 2019, 14 (09)
[75]   Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis [J].
Nagaraja, Vinayak ;
Eslick, Guy D. .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (01) :67-76
[76]   Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities [J].
Napier, Kyle J. ;
Scheerer, Mary ;
Misra, Subhasis .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 6 (05) :112-120
[77]   Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma [J].
Nishii, Takafumi ;
Yashiro, Masakazu ;
Shinto, Osamu ;
Sawada, Tetsuji ;
Ohira, Masaichi ;
Hirakawa, Kosei .
CANCER SCIENCE, 2009, 100 (08) :1397-1402
[78]   Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells [J].
Niwa, H ;
Miyazaki, J ;
Smith, AG .
NATURE GENETICS, 2000, 24 (04) :372-376
[79]   Molecular mechanism to maintain stem cell renewal of ES cells [J].
Niwa, H .
CELL STRUCTURE AND FUNCTION, 2001, 26 (03) :137-148
[80]  
Nosrati A, 2014, INT J MOL CELL MED, V3, P279